{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:57:43Z","timestamp":1790758663652,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R41DC017108"],"award-info":[{"award-number":["R41DC017108"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["JARO"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10162-020-00782-z","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T21:03:26Z","timestamp":1610053406000},"page":"107-126","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Early Physiological and Cellular Indicators of Cisplatin-Induced Ototoxicity"],"prefix":"10.1007","volume":"22","author":[{"given":"Yingying","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Bielefeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey G.","family":"Mellott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir M.","family":"Mafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebenezer N.","family":"Yamoah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2399-8873","authenticated-orcid":false,"given":"Jianxin","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"782_CR1","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/pbc.24236","volume":"60","author":"AL Abujamra","year":"2013","unstructured":"Abujamra AL, Escosteguy JR, Dall'Igna C, Manica D, Cigana LF, Coradini P, Brunetto A, Gregianin LJ (2013) The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy. Pediatr Blood Cancer 60:474\u2013478","journal-title":"Pediatr Blood Cancer"},{"key":"782_CR2","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1083\/jcb.200212085","volume":"161","author":"J Bao","year":"2003","unstructured":"Bao J, Wolpowitz D, Role LW, Talmage DA (2003) Back signaling by the Nrg-1 intracellular domain. J Cell Biol 161:1133\u20131141","journal-title":"J Cell Biol"},{"key":"782_CR3","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/nn1342","volume":"7","author":"J Bao","year":"2004","unstructured":"Bao J, Lin H, Ouyang Y, Lei D, Osman A, Kim T-W, Mei L, Dai P, Ohlemiller KK, Ambron RT (2004) Activity-dependent transcription regulation of PSD-95 by neuregulin-1 and Eos. Nat Neurosci 7:1250\u20131258","journal-title":"Nat Neurosci"},{"key":"782_CR4","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1523\/JNEUROSCI.5277-04.2005","volume":"25","author":"J Bao","year":"2005","unstructured":"Bao J, Lei D, Du Y, Ohlemiller KK, Beaudet AL, Role LW (2005) Requirement of nicotinic acetylcholine receptor subunit \u03b22 in the maintenance of spiral ganglion neurons during aging. J Neurosci 25:3041\u20133045","journal-title":"J Neurosci"},{"key":"782_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.heares.2013.06.004","volume":"304","author":"J Bao","year":"2013","unstructured":"Bao J, Hungerford M, Luxmore R, Ding D, Qiu Z, Lei D, Yang A, Liang R, Ohlemiller KK (2013) Prophylactic and therapeutic functions of drug combinations against noise-induced hearing loss. Hear Res 304:33\u201340","journal-title":"Hear Res"},{"key":"782_CR6","doi-asserted-by":"crossref","unstructured":"Barry MA, Behnke CA, Eastman A (1990) Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 40(10):2353\u20132362","DOI":"10.1016\/0006-2952(90)90733-2"},{"key":"782_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.heares.2013.09.003","volume":"306","author":"EC Bielefeld","year":"2013","unstructured":"Bielefeld EC (2013) Age-related hearing loss patterns in Fischer 344\/NHsd rats with cisplatin-induced hearing loss. Hear Res 306:46\u201353","journal-title":"Hear Res"},{"key":"782_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.heares.2018.09.004","volume":"370","author":"EC Bielefeld","year":"2018","unstructured":"Bielefeld EC, Markle A, DeBacker JR, Harrison RT (2018) Chronotolerance for cisplatin ototoxicity in the rat. Hear Res 370:16\u201321","journal-title":"Hear Res"},{"key":"782_CR9","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s12035-016-0364-7","volume":"55","author":"I Bobylev","year":"2018","unstructured":"Bobylev I, Joshi AR, Barham M, Neiss WF, Lehmann HC (2018) Depletion of mitofusin-2 causes mitochondrial damage in cisplatin-induced neuropathy. Mol Neurobiol 55:1227\u20131235","journal-title":"Mol Neurobiol"},{"key":"782_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00464398","volume":"242","author":"K B\u00f6heim","year":"1985","unstructured":"B\u00f6heim K, Bichler E (1985) Cisplatin-induced ototoxicity: audiometric findings and experimental cochlear pathology. Arch Otorhinolaryngol 242:1\u20136","journal-title":"Arch Otorhinolaryngol"},{"key":"782_CR11","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1038\/s41467-017-01837-1","volume":"8","author":"AM Breglio","year":"2017","unstructured":"Breglio AM, Rusheen AE, Shide ED, Fernandez KA, Spielbauer KK, McLachlin KM, Hall MD, Amable L, Cunningham LL (2017) Cisplatin is retained in the cochlea indefinitely following chemotherapy. Nat Commun 8:1654","journal-title":"Nat Commun"},{"key":"782_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/14992027.2018.1539808","volume":"58","author":"CG Brennan-Jones","year":"2019","unstructured":"Brennan-Jones CG, McMahen C, Van Dalen EC (2019) Cochrane corner: platinum-induced hearing loss after treatment for childhood cancer. Int J Audiol 58:181\u2013184","journal-title":"Int J Audiol"},{"key":"782_CR13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3390\/toxics3020198","volume":"3","author":"A Canta","year":"2015","unstructured":"Canta A, Pozzi E, Carozzi V (2015) Mitochondrial dysfunction in chemotherapy-induced peripheral neuropathy (CIPN). Toxics 3:198\u2013223","journal-title":"Toxics"},{"key":"782_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0378-5955(00)00059-9","volume":"144","author":"RM Cardinaal","year":"2000","unstructured":"Cardinaal RM, de Groot JC, Huizing EH, Veldman JE, Smoorenburg GF (2000) Dose-dependent effect of 8-day cisplatin administration upon the morphology of the albino Guinea pig cochlea. Hear Res 144:135\u2013146","journal-title":"Hear Res"},{"key":"782_CR15","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3390\/toxics3030304","volume":"3","author":"A Chiorazzi","year":"2015","unstructured":"Chiorazzi A, Semperboni S, Marmiroli P (2015) Current view in platinum drug mechanisms of peripheral neurotoxicity. Toxics 3:304\u2013321","journal-title":"Toxics"},{"key":"782_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10162-004-4011-z","volume":"5","author":"MW Church","year":"2004","unstructured":"Church MW, Blakley BW, Burgio DL, Gupta AK (2004) WR-2721 (Amifostine) ameliorates cisplatin-induced hearing loss but causes neurotoxicity in hamsters: dose-dependent effects. J Assoc Res Otolaryngol 5:227\u2013237","journal-title":"J Assoc Res Otolaryngol"},{"key":"782_CR17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/0378-5955(96)00075-5","volume":"98","author":"W Clerici","year":"1996","unstructured":"Clerici W, Hensley K, DiMartino D, Butterfield D (1996) Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants. Hear Res 98:116\u2013124","journal-title":"Hear Res"},{"key":"782_CR18","doi-asserted-by":"crossref","unstructured":"Coughlin L, Morrison RS, Horner PJ, Inman DM (2015) Mitochondrial morphology differences and mitophagy deficit in murine glaucomatous optic nerve. Investig Ophthalmol Vis Sci 56(3):1437\u20131446","DOI":"10.1167\/iovs.14-16126"},{"key":"782_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/010503999424707","volume":"28","author":"A De Lauretis","year":"1999","unstructured":"De Lauretis A, De Capua B, Barbieri MT, Bellussi L, Pass\u00e0li D (1999) ABR evaluation of ototoxicity in cancer patients receiving cisplatin or carboplatin. Scand Audiol 28:139\u2013143","journal-title":"Scand Audiol"},{"key":"782_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1006\/taap.2001.9171","volume":"174","author":"N Dehne","year":"2001","unstructured":"Dehne N, Lautermann J, Petrat F, Rauen U, de Groot H (2001) Cisplatin ototoxicity: involvement of iron and enhanced formation of superoxide anion radicals. Toxicol Appl Pharmacol 174:27\u201334","journal-title":"Toxicol Appl Pharmacol"},{"key":"782_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.heares.2006.07.015","volume":"226","author":"D Ding","year":"2007","unstructured":"Ding D, Jiang H, Wang P, Salvi R (2007) Cell death after co-administration of cisplatin and ethacrynic acid. Hear Res 226:129\u2013139","journal-title":"Hear Res"},{"key":"782_CR22","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3109\/14992027.2010.485595","volume":"49","author":"EJ Einarsson","year":"2010","unstructured":"Einarsson EJ, Petersen H, Wiebe T, Fransson PA, Grenner J, Magnusson M, Mo\u00ebll C (2010) Long term hearing degeneration after platinum-based chemotherapy in childhood. Int J Audiol 49:765\u2013771","journal-title":"Int J Audiol"},{"key":"782_CR23","first-page":"333","volume":"30","author":"SA Fausti","year":"1993","unstructured":"Fausti SA, Frey RH, Henry JA, Olson DJ, Schaffer HI (1993) High-frequency testing techniques and instrumentation for early detection of ototoxicity. J Rehabil Res Dev 30:333\u20133341","journal-title":"J Rehabil Res Dev"},{"key":"782_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.heares.2019.02.006","volume":"375","author":"K Fernandez","year":"2019","unstructured":"Fernandez K, Wafa T, Fitzgerald TS, Cunningham LL (2019) An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity. Hear Res 375:66\u201374","journal-title":"Hear Res"},{"key":"782_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fncel.2017.00252","volume":"11","author":"SP Francis","year":"2017","unstructured":"Francis SP, Cunningham LL (2017) Non-autonomous cellular responses to ototoxic drug-induced stress and death. Front Cell Neurosci 11:252","journal-title":"Front Cell Neurosci"},{"key":"782_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuro.2011.10.010","volume":"33","author":"A Gilardini","year":"2012","unstructured":"Gilardini A, Avila RL, Oggioni N, Rodriguez-Menendez V, Bossi M, Canta A, Cavaletti G, Kirschner DA (2012) Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy. Neurotoxicology 33:1\u20137","journal-title":"Neurotoxicology"},{"key":"782_CR27","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1200\/JCO.1989.7.10.1457","volume":"7","author":"SW Hansen","year":"1989","unstructured":"Hansen SW, Helweg-Larsen S, Trojaborg W (1989) Long-term neurotoxicity in patients treated with cisplatin, vinblastine, and bleomycin for metastatic germ cell cancer. J Clin Oncol 7:1457\u20131461","journal-title":"J Clin Oncol"},{"key":"782_CR28","doi-asserted-by":"publisher","first-page":"E78","DOI":"10.1002\/lary.24948","volume":"125","author":"RT Harrison","year":"2015","unstructured":"Harrison RT, DeBacker JR, Bielefeld EC (2015) A low-dose regimen of cisplatin before high-dose cisplatin potentiates ototoxicity. Laryngoscope 125:E78\u2013E83","journal-title":"Laryngoscope"},{"key":"782_CR29","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/CAD.0000000000000395","volume":"27","author":"RT Harrison","year":"2016","unstructured":"Harrison RT, Seiler BM, Bielefeld EC (2016) Ototoxicity of 12 mg\/kg cisplatin in the Fischer 344\/NHsd rat using multiple dosing strategies. Anti-Cancer Drugs 27:780\u2013786","journal-title":"Anti-Cancer Drugs"},{"key":"782_CR30","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1002\/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO;2-J","volume":"39","author":"D Hayes","year":"1977","unstructured":"Hayes D, Cvitkovic E, Colbey R, Schreiner E, Helson L, Krakoff J (1977) High dose cis-platinum diammine dichloride. Cancer 39:1372\u20131381","journal-title":"Cancer"},{"key":"782_CR31","first-page":"731","volume":"16","author":"R Hinojosa","year":"1995","unstructured":"Hinojosa R, Riggs LC, Strauss M, Matz GJ (1995) Temporal bone histopathology of cisplatin ototoxicity. Am J Otol 16:731\u2013740","journal-title":"Am J Otol"},{"key":"782_CR32","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1002\/glia.20761","volume":"56","author":"KR Jessen","year":"2008","unstructured":"Jessen KR, Mirsky R (2008) Negative regulation of myelination: relevance for development, injury, and demyelinating disease. Glia 56:1552\u20131565","journal-title":"Glia"},{"key":"782_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.5306\/wjco.v8.i4.329","volume":"8","author":"O Kanat","year":"2017","unstructured":"Kanat O, Ertas H, Caner B (2017) Platinum-induced neurotoxicity: a review of possible mechanisms. World J Clin Oncol 8:329\u2013335","journal-title":"World J Clin Oncol"},{"key":"782_CR34","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.toxlet.2015.06.012","volume":"237","author":"T Karasawa","year":"2015","unstructured":"Karasawa T, Steyger PS (2015) An integrated view of cisplatin-induced nephrotoxicity and ototoxicity. Toxicol Lett 237:219\u2013227","journal-title":"Toxicol Lett"},{"key":"782_CR35","doi-asserted-by":"publisher","first-page":"8588","DOI":"10.1200\/JCO.2004.00.5355","volume":"23","author":"KRG Knight","year":"2005","unstructured":"Knight KRG, Kraemer DF, Neuwelt EA (2005) Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol 23:8588\u20138596","journal-title":"J Clin Oncol"},{"key":"782_CR36","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1177\/019459988108900226","volume":"89","author":"S Komune","year":"1981","unstructured":"Komune S, Asakuma S, Snow JB Jr (1981) Pathophysiology of the ototoxicity of cis-diamminedichloroplatinum. Otolaryngol Head Neck Surg 89:275\u2013282","journal-title":"Otolaryngol Head Neck Surg"},{"key":"782_CR37","unstructured":"Kujawa SG, Liberman MC (2009) Adding insult to injury: cochlear nerve degeneration after \"temporary\" noise-induced hearing loss. J Neurosci. 29(45):14077\u201314085"},{"key":"782_CR38","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3109\/00016489109138427","volume":"111","author":"G Laurell","year":"1991","unstructured":"Laurell G, Bagger-Sj\u00f6b\u00e4ck D (1991) Degeneration of the organ of Corti following intravenous administration of cisplatin. Acta Otolaryngol 111:891\u2013898","journal-title":"Acta Otolaryngol"},{"key":"782_CR39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0378-5955(97)00154-8","volume":"114","author":"J Lautermann","year":"1997","unstructured":"Lautermann J, Crann SA, McLaren J, Schacht J (1997) Glutathione-dependent antioxidant systems in the mammalian inner ear: effects of aging, ototoxic drugs and noise. Hear Res 114:75\u201382","journal-title":"Hear Res"},{"key":"782_CR40","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1083\/jcb.200411047","volume":"170","author":"J Lee","year":"2005","unstructured":"Lee J, Gravel M, Zhang R, Thibault P, Braun PE (2005a) Process outgrowth in oligodendrocytes is mediated by CNP, a novel microtubule assembly myelin protein. J Cell Biol 170:661\u2013673","journal-title":"J Cell Biol"},{"key":"782_CR41","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00415-005-0621-6","volume":"252","author":"Y-C Lee","year":"2005","unstructured":"Lee Y-C, Soong B-W, Liu Y-T, Lin K-P, Kao K-P, Wu Z-A (2005b) Median nerve motor conduction velocity is concordant with myelin protein zero gene mutation. J Neurol 252:151\u2013155","journal-title":"J Neurol"},{"key":"782_CR42","doi-asserted-by":"crossref","unstructured":"Liberman MC, Kujawa SG (2017) Cochlear synaptopathy in acquired sensorineural hearing loss: Manifestations and mechanisms. Hear Res 349:138\u2013147","DOI":"10.1016\/j.heares.2017.01.003"},{"key":"782_CR43","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.fct.2016.08.033","volume":"97","author":"Y-J Lee","year":"2016","unstructured":"Lee Y-J, Lee GJ, Yi SS, Heo S-H, Park C-R, Nam H-S, Cho M-K, Lee S-H (2016) Cisplatin and resveratrol induce apoptosis and autophagy following oxidative stress in malignant mesothelioma cells. Food Chem Toxicol 97:96\u2013107","journal-title":"Food Chem Toxicol"},{"key":"782_CR44","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.heares.2013.03.012","volume":"302","author":"E Lobarinas","year":"2013","unstructured":"Lobarinas E, Salvi R, Ding D (2013) Insensitivity of the audiogram to carboplatin induced inner hair cell loss in chinchillas. Hear Res 302:113\u2013120","journal-title":"Hear Res"},{"key":"782_CR45","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/00001813-200506000-00013","volume":"16","author":"ED Lynch","year":"2005","unstructured":"Lynch ED, Gu R, Pierce C, Kil J (2005) Combined oral delivery of ebselen and allopurinol reduces multiple cisplatin toxicities in rat breast and ovarian cancer models while enhancing anti-tumor activity. Anti-Cancer Drugs 16:569\u2013579","journal-title":"Anti-Cancer Drugs"},{"key":"782_CR46","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1001\/archotol.1997.01900090094014","volume":"123","author":"R Madasu","year":"1997","unstructured":"Madasu R, Ruckenstein M, Leake F, Steere E, Robbins K (1997) Ototoxic effects of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 123:978\u2013981","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"782_CR47","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3109\/14992027.2012.688143","volume":"51","author":"GP McMillan","year":"2012","unstructured":"McMillan GP, Konrad-Martin D, Dille MF (2012) Accuracy of distortion-product otoacoustic emissions-based ototoxicity monitoring using various primary frequency step-sizes. Int J Audiol 51:689\u2013696","journal-title":"Int J Audiol"},{"key":"782_CR48","doi-asserted-by":"crossref","unstructured":"Mukherjea D, Rybak LP (2011) Pharmacogenomics of cisplatin-induced ototoxicity. Pharmacogenomics 12(7):1039\u20131050","DOI":"10.2217\/pgs.11.48"},{"key":"782_CR49","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/cne.23238","volume":"521","author":"MA Muniak","year":"2013","unstructured":"Muniak MA, Rivas A, Montey KL, May BJ, Francis HW, Ryugo DK (2013) 3D model of frequency representation in the cochlear nucleus of the CBA\/J mouse. J Comp Neurol 521:1510\u20131532","journal-title":"J Comp Neurol"},{"key":"782_CR50","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0378-5955(00)00191-X","volume":"149","author":"KK Ohlemiller","year":"2000","unstructured":"Ohlemiller KK, Wright JS, Heidbreder AF (2000a) Vulnerability to noise-induced hearing loss in \u2018middle-aged\u2019and young adult mice: a dose\u2013response approach in CBA, C57BL, and BALB inbred strains. Hear Res 149:239\u2013247","journal-title":"Hear Res"},{"key":"782_CR51","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s101620010043","volume":"1","author":"KK Ohlemiller","year":"2000","unstructured":"Ohlemiller KK, McFadden SL, Ding D-L, Lear PM, Ho Y-S (2000b) Targeted mutation of the gene for cellular glutathione peroxidase (Gpx1) increases noise-induced hearing loss in mice. J Assoc Res Otolaryngol 1:243\u2013254","journal-title":"J Assoc Res Otolaryngol"},{"key":"782_CR52","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.nbd.2010.11.017","volume":"41","author":"JL Podratz","year":"2011","unstructured":"Podratz JL, Knight AM, Ta LE, Staff NP, Gass JM, Genelin K, Schlattau A, Lathroum L, Windebank AJ (2011) Cisplatin induced mitochondrial DNA damage in dorsal root ganglion neurons. Neurobiol Dis 41:661\u2013668","journal-title":"Neurobiol Dis"},{"key":"782_CR53","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.nbd.2016.10.003","volume":"97","author":"JL Podratz","year":"2017","unstructured":"Podratz JL, Lee H, Knorr P, Koehler S, Forsythe S, Lambrecht K, Arias S, Schmidt K, Steinhoff G, Yudintsev G (2017) Cisplatin induces mitochondrial deficits in Drosophila larval segmental nerve. Neurobiol Dis 97:60\u201369","journal-title":"Neurobiol Dis"},{"key":"782_CR54","unstructured":"R Core Team (2019) R: A language and environment for statistical computing. In: R Foundation for Statistical Computing, Vienna, Austria URL https:\/\/www.R-project.org\/"},{"key":"782_CR55","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1600-0773.1995.tb00167.x","volume":"76","author":"R Ravi","year":"1995","unstructured":"Ravi R, Somani SM, Rybak LP (1995) Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol Toxicol 76:386\u2013394","journal-title":"Pharmacol Toxicol"},{"key":"782_CR56","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/AUD.0b013e318181ad99","volume":"29","author":"KM Reavis","year":"2008","unstructured":"Reavis KM, Phillips DS, Fausti SA, Gordon JS, Helt WJ, Wilmington D, Bratt GW, Konrad-Martin D (2008) Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss. Ear Hear 29:875\u2013893","journal-title":"Ear Hear"},{"key":"782_CR57","first-page":"19","volume":"66","author":"R Reddel","year":"1982","unstructured":"Reddel R, Kefford R, Grant J, Coates A, Fox T, Tattersall M (1982) Ototoxicity in patients receiving cisplatin: importance of dose and method of drug administration. Cancer Treat Rep 66:19\u201323","journal-title":"Cancer Treat Rep"},{"key":"782_CR58","doi-asserted-by":"publisher","first-page":"4945","DOI":"10.1172\/JCI71353","volume":"123","author":"S Roy","year":"2013","unstructured":"Roy S, Ryals MM, Van den Bruele AB, Fitzgerald TS, Cunningham LL (2013) Sound preconditioning therapy inhibits ototoxic hearing loss in mice. J Clin Invest 123:4945\u20134949","journal-title":"J Clin Invest"},{"key":"782_CR59","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.heares.2006.09.015","volume":"226","author":"LP Rybak","year":"2007","unstructured":"Rybak LP, Whitworth CA, Mukherjea D, Ramkumar V (2007) Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res 226:157\u2013167","journal-title":"Hear Res"},{"key":"782_CR60","doi-asserted-by":"crossref","unstructured":"Rybak LP, Mukherjea D, Ramkumar V (2019) Mechanisms of cisplatin-induced ototoxicity and prevention. Seminars in hearing, Vol. 40. Thieme Medical Publishers. Pp. 197-204","DOI":"10.1055\/s-0039-1684048"},{"key":"782_CR61","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fncel.2017.00338","volume":"11","author":"S Sheth","year":"2017","unstructured":"Sheth S, Mukherjea D, Rybak LP, Ramkumar V (2017) Mechanisms of cisplatin-induced ototoxicity and otoprotection. Front Cell Neurosci 11:338","journal-title":"Front Cell Neurosci"},{"key":"782_CR62","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0165-5876(01)00455-4","volume":"59","author":"P Stavroulaki","year":"2001","unstructured":"Stavroulaki P, Apostolopoulos N, Segas J, Tsakanikos M, Adamopoulos G (2001) Evoked otoacoustic emissions\u2014an approach for monitoring cisplatin induced ototoxicity in children. Int J Pediatr Otorhinolaryngol 59:47\u201357","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"782_CR63","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/brain\/awq374","volume":"134","author":"F Taioli","year":"2011","unstructured":"Taioli F, Cabrini I, Cavallaro T, Acler M, Fabrizi GM (2011) Inherited demyelinating neuropathies with micromutations of peripheral myelin protein 22 gene. Brain 134:608\u2013617","journal-title":"Brain"},{"key":"782_CR64","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.heares.2015.07.002","volume":"328","author":"J Tang","year":"2015","unstructured":"Tang J, Qian Y, Li H, Kopecky BJ, Ding D, Ou HC, DeCook R, Chen X, Sun Z, Kobel M (2015) Canertinib induces ototoxicity in three preclinical models. Hear Res 328:59\u201366","journal-title":"Hear Res"},{"key":"782_CR65","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.conb.2016.03.006","volume":"39","author":"C Taveggia","year":"2016","unstructured":"Taveggia C (2016) Schwann cells\u2013axon interaction in myelination. Curr Opin Neurobiol 39:24\u201329","journal-title":"Curr Opin Neurobiol"},{"key":"782_CR66","doi-asserted-by":"crossref","unstructured":"van Ruijven MWM, de Groot JCMJ, Klis SFL, Smoorenburg GF (2005) The cochlear targets of cisplatin: An electrophysiological and morphological time-sequence study. Hear Res 205(1-2):241\u2013248","DOI":"10.1016\/j.heares.2005.03.023"},{"key":"782_CR67","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/BF00464252","volume":"239","author":"G van Zeijl","year":"1984","unstructured":"van Zeijl G, Conijn E, Rodenburg M, Tange R, Brocaar M (1984) Analysis of hearing loss due to cis-diamminedichloroplatinum-II. Arch Oto-Rhino-Laryngol 239:255\u2013262","journal-title":"Arch Oto-Rhino-Laryngol"},{"key":"782_CR68","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1136\/jnnp-2013-305334","volume":"85","author":"R Velasco","year":"2014","unstructured":"Velasco R, Bruna J, Briani C, Argyriou AA, Cavaletti G, Alberti P, Frigeni B, Cacciavillani M, Lonardi S, Cortinovis D (2014) Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients. J Neurol Neurosurg Psychiatry 85:392\u2013398","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"782_CR69","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s00405-016-4117-z","volume":"274","author":"S Waissbluth","year":"2017","unstructured":"Waissbluth S, Peleva E, Daniel SJ (2017) Platinum-induced ototoxicity: a review of prevailing ototoxicity criteria. Eur Arch Otorhinolaryngol 274:1187\u20131196","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"782_CR70","doi-asserted-by":"publisher","first-page":"14487","DOI":"10.1038\/ncomms14487","volume":"8","author":"G Wan","year":"2017","unstructured":"Wan G, Corfas G (2017) Transient auditory nerve demyelination as a new mechanism for hidden hearing loss. Nat Commun 8:14487","journal-title":"Nat Commun"},{"key":"782_CR71","doi-asserted-by":"crossref","unstructured":"Wu Y, Ma Y, Liu Z, Geng Q, Chen Z, Zhang Y (2017) Alterations of myelin morphology and oligodendrocyte development in early stage of Alzheimer\u2019s disease mouse model. Neurosci Lett 642:102\u2013106","DOI":"10.1016\/j.neulet.2017.02.007"}],"container-title":["Journal of the Association for Research in Otolaryngology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10162-020-00782-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10162-020-00782-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10162-020-00782-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T16:51:58Z","timestamp":1615308718000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10162-020-00782-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["782"],"URL":"https:\/\/doi.org\/10.1007\/s10162-020-00782-z","relation":{},"ISSN":["1525-3961","1438-7573"],"issn-type":[{"value":"1525-3961","type":"print"},{"value":"1438-7573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"14 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"J.B. is one of the co-founders of Gateway Biotechnology Inc. and has disclosed potential interests fully to Northeast Ohio Medical University. Other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Disclosure Statement"}}]}}